Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

about

Measuring the biological effect of presurgical metformin treatment in endometrial cancer.

P2860

Q36547907-A7FC384E-8454-4F3C-8638-5BEFAA32B370

P2860

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

Item

http://www.wikidata.org/entity/Q44667403

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

@en

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

@nl

type

Item

label

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

@en

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

@nl

prefLabel

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

@en

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

@nl

P1476

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial

@en

P2093

P J Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Assessment of pancreatic β-cell function: review of methods and clinical applications

Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging

Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.

P304

270-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13697137.2014.954997

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267273178

http://www.w3.org/2001/XMLSchema#string

P698

25333776

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

metformin

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

about

P2860

P2860

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921